Raya Mawad

856 total citations
38 papers, 459 citations indexed

About

Raya Mawad is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Raya Mawad has authored 38 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 16 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Raya Mawad's work include Acute Myeloid Leukemia Research (19 papers), CAR-T cell therapy research (9 papers) and Multiple Myeloma Research and Treatments (9 papers). Raya Mawad is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), CAR-T cell therapy research (9 papers) and Multiple Myeloma Research and Treatments (9 papers). Raya Mawad collaborates with scholars based in United States, Spain and France. Raya Mawad's co-authors include John M. Pagel, Elihu H. Estey, Wendy Stock, Alice S. Mims, Asad Bashey, Farhad Ravandi, Brenda M. Sandmaier, James M. Foran, William Blum and Ted Gooley and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Raya Mawad

36 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raya Mawad United States	13	264	214	127	98	88	38	459
O. J. H. M. Verhagen Netherlands	13	219 0.8×	108 0.5×	128 1.0×	157 1.6×	79 0.9×	25	494
Jenna D. Goldberg United States	16	513 1.9×	366 1.7×	178 1.4×	131 1.3×	188 2.1×	27	638
Satyajit Kosuri United States	12	247 0.9×	150 0.7×	128 1.0×	61 0.6×	27 0.3×	47	420
H. Kasparu Austria	10	249 0.9×	227 1.1×	167 1.3×	75 0.8×	63 0.7×	28	513
Jenna D. Goldberg United States	4	276 1.0×	275 1.3×	170 1.3×	106 1.1×	134 1.5×	12	467
Zhao Yang United States	10	233 0.9×	199 0.9×	177 1.4×	57 0.6×	73 0.8×	21	408
Larysa Sanchez United States	12	376 1.4×	335 1.6×	253 2.0×	122 1.2×	118 1.3×	65	606
Tara Gregory United States	11	268 1.0×	335 1.6×	289 2.3×	78 0.8×	47 0.5×	31	557
Catherine Spier United States	8	169 0.6×	168 0.8×	109 0.9×	150 1.5×	57 0.6×	10	384
Rama Al Hamed France	9	308 1.2×	223 1.0×	236 1.9×	53 0.5×	21 0.2×	11	487

Countries citing papers authored by Raya Mawad

Since Specialization

Citations

This map shows the geographic impact of Raya Mawad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raya Mawad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raya Mawad more than expected).

Fields of papers citing papers by Raya Mawad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raya Mawad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raya Mawad. The network helps show where Raya Mawad may publish in the future.

Co-authorship network of co-authors of Raya Mawad

This figure shows the co-authorship network connecting the top 25 collaborators of Raya Mawad. A scholar is included among the top collaborators of Raya Mawad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raya Mawad. Raya Mawad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abrams, Hannah R., Helene Starks, Mary‐Elizabeth M. Percival, et al.. (2025). Logistical and Non-Medical Barriers to Hematopoietic Cell Transplantation (HCT) and Chimeric Antigen Receptor T-Cell (CAR T) Therapy: A Survey of National Comprehensive Cancer Network (NCCN) Centers. Transplantation and Cellular Therapy. 31(2). S51–S52. 1 indexed citations

Appelbaum, Jacob, Kathryn Russell, Xueyan Chen, et al.. (2024). Hematopoietic stem cell transplant for adults with mixed phenotypic acute leukemia.. Journal of Clinical Oncology. 42(16_suppl). 6517–6517.

Milano, Filippo, Brenda M. Sandmaier, Mary‐Elizabeth M. Percival, et al.. (2024). CLAG-M or FLAG-Ida Followed Immediately By Allogeneic Hematopoietic Cell Transplantation for Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasm. Blood. 144(Supplement 1). 265–265.

Madan, Sumit, Brea Lipe, Eva Medvedova, et al.. (2023). P-292 Ongoing phase 1 study of HPN217, a half-life extended tri-specific T cell activating construct (TriTAC) targeting B cell maturation antigen (BCMA) for relapsed/refractory multiple myeloma (MM). Clinical Lymphoma Myeloma & Leukemia. 23. S198–S198. 1 indexed citations

Ravandi, Farhad, Asad Bashey, James M. Foran, et al.. (2023). Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia. Blood Advances. 7(21). 6492–6505. 24 indexed citations

LaBella, Dominic, Helmut König, Daniel Egan, et al.. (2022). The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome. Frontiers in Oncology. 12. 911745–911745. 1 indexed citations

DiNardo, Courtney D., Gautam Borthakur, Brian Ball, et al.. (2021). Phase 1/2 Study Investigating CC-90011, a Potent, Selective, and Reversible Oral Inhibitor of Lysine-Specific Demethylase 1 (LSD1), Plus Concurrent Venetoclax (VEN) and Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML). Blood. 138(Supplement 1). 4430–4430. 2 indexed citations

Bailey, Neil A., William Bensinger, Daniel Egan, et al.. (2020). Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Blood. 136(Supplement 1). 34–34. 1 indexed citations

Ravandi, Farhad, Asad Bashey, Wendy Stock, et al.. (2020). Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of Vibecotamab (XmAb14045), a CD123 x CD3 T Cell-Engaging Bispecific Antibody; Initial Results of a Phase 1 Study. Blood. 136(Supplement 1). 4–5. 54 indexed citations

10.

Graber, Jerome, et al.. (2018). Two Cases of Pembrolizumab Therapy for CNS lymphoma (P6.136). Neurology. 90(15_supplement). 1 indexed citations

11.

Ravandi, Farhad, Asad Bashey, James M. Foran, et al.. (2018). Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of XmAb14045, a CD123 x CD3 T Cell-Engaging Bispecific Antibody: Initial Results of a Phase 1 Study. Blood. 132(Supplement 1). 763–763. 47 indexed citations

12.

Shadman, Mazyar, Raya Mawad, Kathleen Shannon‐Dorcy, et al.. (2015). Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome. American Journal of Hematology. 90(6). 483–486. 23 indexed citations

13.

Mawad, Raya, Pamela S. Becker, Paul C. Hendrie, et al.. (2015). Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high‐risk MDS. British Journal of Haematology. 172(2). 238–245. 24 indexed citations

14.

Mawad, Raya, Ted Gooley, Joseph G. Rajendran, et al.. (2014). Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 20(9). 1363–1368. 42 indexed citations

15.

Hamdi, Amir, Raya Mawad, Roland L. Bassett, et al.. (2014). Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(11). 1767–1771. 35 indexed citations

16.

Mawad, Raya, Jack M. Lionberger, & John M. Pagel. (2013). Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia. Current Hematologic Malignancy Reports. 8(2). 132–140. 11 indexed citations

17.

Mawad, Raya, Ajay K. Gopal, Oliver W. Press, et al.. (2013). A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL). Blood. 122(21). 4191–4191. 2 indexed citations

18.

Mawad, Raya & Elihu H. Estey. (2012). Acute Myeloid Leukemia with Normal Cytogenetics. Current Oncology Reports. 14(5). 359–368. 9 indexed citations

19.

Mawad, Raya, Paul V. O’Donnell, Ted Gooley, et al.. (2012). Hematopoietic Bone Marrow Transplantation (BMT) for Patients with High-Risk Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), or Myelodysplastic Syndrome (MDS) Using HLA-Haploidentical Related Donors: A Trial Using Radiolabeled Anti-CD45 Antibody Combined with Immunosuppression Before and After BMT. Blood. 120(21). 4164–4164. 1 indexed citations

20.

Mawad, Raya, Ai‐Ru Hsieh, & Lloyd E. Damon. (2009). Graft-versus-Host Disease Presenting With Pancytopenia After En Bloc Multiorgan Transplantation: Case Report and Literature Review. Transplantation Proceedings. 41(10). 4431–4433. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact